Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ari Zimran

Showing results (231-240 of 238) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 238 results.
Blood|September 9, 2011
Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher diseaseAri Zimran, Einat Brill-Almon, Raul Chertkoff, et al.
Journal of Inherited Metabolic Disease|April 4, 2020
The definition of neuronopathic Gaucher diseaseRaphael Schiffmann, Jeff Sevigny, Arndt Rolfs, et al.
Blood Cells, Molecules & Diseases|December 15, 2010
Early access experience with VPRIV(®): recommendations for 'core data' collectionDerralynn A Hughes, Moeen Al-Sayed, Nadia Belmatoug, et al.
Diagnostics (Basel, Switzerland)|September 9, 2023
Insights into the Value of Lyso-Gb1 as a Predictive Biomarker in Treatment-Naïve Patients with Gaucher Disease Type 1 in the LYSO-PROOF StudyFilipa Curado, Sabine Rösner, Susanne Zielke, et al.
Journal of Medical Genetics|October 26, 2019
Pharmacologic properties of high-dose ambroxol in four patients with Gaucher disease and myoclonic epilepsyYoon-Myung Kim, Mi-Sun Yum, Sun Hee Heo, et al.
Blood Cells, Molecules & Diseases|October 7, 2009
Force majeure: therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher diseaseCarla E M Hollak, Stephan vom Dahl, Johannes M F G Aerts, et al.
Internal Medicine Journal|November 11, 2018
Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiativeAtul Mehta, David J Kuter, Sam S Salek, et al.
Seminars in Hematology|October 7, 2004
Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patientsNeal J Weinreb, Mario C Aggio, Hans C Andersson, et al.
Pageof 24

Showing results (231-240 of 238) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 238 results.
Blood|September 9, 2011
Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher diseaseAri Zimran, Einat Brill-Almon, Raul Chertkoff, et al.
Journal of Inherited Metabolic Disease|April 4, 2020
The definition of neuronopathic Gaucher diseaseRaphael Schiffmann, Jeff Sevigny, Arndt Rolfs, et al.
Blood Cells, Molecules & Diseases|December 15, 2010
Early access experience with VPRIV(®): recommendations for 'core data' collectionDerralynn A Hughes, Moeen Al-Sayed, Nadia Belmatoug, et al.
Diagnostics (Basel, Switzerland)|September 9, 2023
Insights into the Value of Lyso-Gb1 as a Predictive Biomarker in Treatment-Naïve Patients with Gaucher Disease Type 1 in the LYSO-PROOF StudyFilipa Curado, Sabine Rösner, Susanne Zielke, et al.
Journal of Medical Genetics|October 26, 2019
Pharmacologic properties of high-dose ambroxol in four patients with Gaucher disease and myoclonic epilepsyYoon-Myung Kim, Mi-Sun Yum, Sun Hee Heo, et al.
Blood Cells, Molecules & Diseases|October 7, 2009
Force majeure: therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher diseaseCarla E M Hollak, Stephan vom Dahl, Johannes M F G Aerts, et al.
Internal Medicine Journal|November 11, 2018
Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiativeAtul Mehta, David J Kuter, Sam S Salek, et al.
Seminars in Hematology|October 7, 2004
Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patientsNeal J Weinreb, Mario C Aggio, Hans C Andersson, et al.
Pageof 24